Description
BSE announces the upcoming listing and admission to dealings of equity shares of Accretion Nutraveda Limited on the SME segment.
Summary
BSE has announced that equity shares of Accretion Nutraveda Limited will be listed and admitted to dealings on the Exchange’s SME segment. The company has been assigned scrip code 544694, symbol ANL, and ISIN INE1KVQ01019. The exact listing date and security details will be communicated through a separate notice.
Key Points
- Accretion Nutraveda Limited equity shares to be listed on BSE SME segment
- Scrip Code: 544694
- Symbol: ANL
- ISIN: INE1KVQ01019
- Listing date to be announced separately
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE
Regulatory Changes
No regulatory changes introduced in this circular.
Compliance Requirements
Trading members are informed to note the scrip details for future trading activities once listing occurs.
Important Dates
- Notice Date: February 3, 2026
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement with minimal market-wide impact. The listing provides investors access to a new SME segment company. Trading members should update their systems with the scrip details once the listing date is confirmed.
Impact Justification
Routine new listing announcement for SME segment company with limited market-wide impact